(Q34269238)
Statements
1 reference
First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro (English)
1 reference
Thomas Lund
1 reference
Kent Søe
1 reference
Niels Abildgaard
1 reference
Patrick Garnero
1 reference
Per T Pedersen
1 reference
Tina Ormstrup
1 reference
Jean-Marie Delaissé
1 reference
Torben Plesner
1 reference
22 July 2010
1 reference
1 reference
85
1 reference
4
1 reference
290-299
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference